CD8A and melanoma: PBRM1 levels are inversely correlated with CD8+ cytotoxic T-cell infiltration, which suggests immunotherapeutic potential in RTs.297 ARID2 mutations are significantly more prevalent than PBRM1 mutations in melanoma.